These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 26686042)

  • 21. Surgical follow-up costs disproportionately impact low-income patients.
    Scott AR; Rush AJ; Naik AD; Berger DH; Suliburk JW
    J Surg Res; 2015 Nov; 199(1):32-8. PubMed ID: 26013443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Financial Toxicity in Swiss Cancer Patients Treated with Proton Therapy: An Observational Cross-Sectional Study on Self-Reported Outcome.
    Bachtiary B; Grawehr L; Grillo Ruggieri F; Held U; Weber DC
    Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shared burden: the association between cancer diagnosis, financial toxicity, and healthcare cost-related coping mechanisms by family members of non-elderly patients in the USA.
    Kazzi B; Chino F; Kazzi B; Jain B; Tian S; Paguio JA; Yao JS; Muralidhar V; Mahal BA; Nguyen PL; Sanford NN; Dee EC
    Support Care Cancer; 2022 Nov; 30(11):8905-8917. PubMed ID: 35877007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Pilot Study of a Comprehensive Financial Navigation Program in Patients With Cancer and Caregivers.
    Watabayashi K; Steelquist J; Overstreet KA; Leahy A; Bradshaw E; Gallagher KD; Balch AJ; Lobb R; Lavell L; Linden H; Ramsey SD; Shankaran V
    J Natl Compr Canc Netw; 2020 Oct; 18(10):1366-1373. PubMed ID: 33022646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The patient-level effect of the cost of Cancer care - financial burden in German Cancer patients.
    Mehlis K; Witte J; Surmann B; Kudlich M; Apostolidis L; Walther J; Jäger D; Greiner W; Winkler EC
    BMC Cancer; 2020 Jun; 20(1):529. PubMed ID: 32503459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of Patient-Centered Financial Stress in Patients With Locally Advanced Head and Neck Cancer.
    de Souza JA; Kung S; O'Connor J; Yap BJ
    J Oncol Pract; 2017 Apr; 13(4):e310-e318. PubMed ID: 28195811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical financial hardship among cancer survivors in the United States.
    Zheng Z; Jemal A; Han X; Guy GP; Li C; Davidoff AJ; Banegas MP; Ekwueme DU; Yabroff KR
    Cancer; 2019 May; 125(10):1737-1747. PubMed ID: 30663039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coping Mechanisms for Financial Toxicity Among Patients With Metastatic Prostate Cancer: A Survey-based Assessment.
    Joyce DD; Schulte PJ; Kwon ED; Dusetzina SB; Moses KA; Sharma V; Penson DF; Tilburt JC; Boorjian SA
    J Urol; 2023 Aug; 210(2):290-298. PubMed ID: 37416955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic burden of gastrointestinal cancer under the protection of the New Rural Cooperative Medical Scheme in a region of rural China with high incidence of oesophageal cancer: cross-sectional survey.
    Li X; Cai H; Wang C; Guo C; He Z; Ke Y
    Trop Med Int Health; 2016 Jul; 21(7):907-16. PubMed ID: 27125226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pilot Feasibility Study of an Oncology Financial Navigation Program.
    Shankaran V; Leahy T; Steelquist J; Watabayashi K; Linden H; Ramsey S; Schwartz N; Kreizenbeck K; Nelson J; Balch A; Singleton E; Gallagher K; Overstreet K
    J Oncol Pract; 2018 Feb; 14(2):e122-e129. PubMed ID: 29272200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Financial toxicity assessment and associated factors analysis of patients with cancer in China.
    Qiu Z; Yao L; Jiang J
    Support Care Cancer; 2023 Apr; 31(5):264. PubMed ID: 37058171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient-reported benefit from proposed interventions to reduce financial toxicity during cancer treatment.
    Aviki EM; Thom B; Braxton K; Chi AJ; Manning-Geist B; Chino F; Brown CL; Abu-Rustum NR; Gany FM
    Support Care Cancer; 2022 Mar; 30(3):2713-2721. PubMed ID: 34822002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mixed-Methods Study on the Responsiveness of the Comprehensive Score for Financial Toxicity Among People With Multiple Myeloma.
    Fiala MA; Leblanc MR; Coccia KW; Bandaru S; Silberstein AE; Coles T; Vij R
    JCO Oncol Pract; 2024 Jun; 20(6):835-842. PubMed ID: 38447085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Out-of-pocket expenses incurred by patients obtaining free breast cancer care in Haiti: A pilot study.
    O'Neill KM; Mandigo M; Pyda J; Nazaire Y; Greenberg SL; Gillies R; Damuse R
    Surgery; 2015 Sep; 158(3):747-55. PubMed ID: 26150200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Out-of-pocket Cost Burden in Pediatric Inflammatory Bowel Disease: A Cross-sectional Cohort Analysis.
    Sin AT; Damman JL; Ziring DA; Gleghorn EE; Garcia-Careaga MG; Gugig RR; Hunter AK; Burgis JC; Bass DM; Park KT
    Inflamm Bowel Dis; 2015 Jun; 21(6):1368-77. PubMed ID: 25839776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient-Reported Out-of-Pocket Costs and Financial Toxicity During Early-Phase Oncology Clinical Trials.
    Huey RW; George GC; Phillips P; White R; Fu S; Janku F; Karp DD; Naing A; Piha-Paul S; Subbiah V; Tsimberidou AM; Pant S; Yap TA; Rodon J; Meric-Bernstam F; Shih YT; Hong DS
    Oncologist; 2021 Jul; 26(7):588-596. PubMed ID: 33783054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-Reported Risk Factors for Financial Distress and Attitudes Regarding Cost Discussions in Cancer Care: A Single-Institution Cross-Sectional Pilot Study of Breast Reconstruction Recipients.
    Asaad M; Bailey C; Boukovalas S; Liu J; Clemens MW; Selber J; Butler CE; Offodile AC
    Plast Reconstr Surg; 2021 Apr; 147(4):587e-595e. PubMed ID: 33776027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Financial Burden Among Patients With Lung Cancer in a Publically Funded Health Care System.
    Ezeife DA; Morganstein BJ; Lau S; Law JH; Le LW; Bredle J; Cella D; Doherty MK; Bradbury P; Liu G; Sacher A; Shepherd FA; Leighl NB
    Clin Lung Cancer; 2019 Jul; 20(4):231-236. PubMed ID: 30797721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The high cost burden of third- to fifth-line treatments for multiple myeloma: unsustainable and unaffordable.
    Jensen C
    J Manag Care Spec Pharm; 2021 Sep; 27(9):1321-1324. PubMed ID: 34464211
    [No Abstract]   [Full Text] [Related]  

  • 40. Financial burden of healthcare for cancer patients with social medical insurance: a multi-centered study in urban China.
    Mao W; Tang S; Zhu Y; Xie Z; Chen W
    Int J Equity Health; 2017 Oct; 16(1):180. PubMed ID: 29017542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.